A Novel Four-Gene Prognostic Signature for Prediction of Survival in Patients with Soft Tissue Sarcoma.

Cancers (Basel) · 2021 · PMC8616347 · PMID 34830998

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

weakly significantno p-value reported

showed at least a weakly significant advantage of combined doxorubicin-based over doxorubicin alone chemotherapy in 5044 patients [ 47 ].

also in 1,387 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.